title: Plasma amyloid beta peptides: an Alzheimer's conundrum or a more accessible Alzheimer's biomarker?
authors.affiliation: a Center for Healthy Brain Ageing (CHeBA), School of Psychiatry , University of NSW , Sydney , Australia.|b School of Medical Sciences (SOMS) , University of NSW , Sydney , Australia.|c Bioanalytical Mass Spectrometry Facility (BMSF) , University of NSW , Sydney , Australia.
authors.forename: Anne
authors.initials: A
authors.lastname: Poljak
authors.affiliation: a Center for Healthy Brain Ageing (CHeBA), School of Psychiatry , University of NSW , Sydney , Australia.|d Neuropsychiatric Institute, Prince of Wales Hospital , University of NSW , Sydney , Australia.|e School of Psychiatry , University of NSW , Sydney , Australia.
authors.forename: Perminder Singh
authors.initials: PS
authors.lastname: Sachdev
mesh_terms: D000544:Alzheimer Disease / Q000097:blood*; D016229:Amyloid beta-Peptides / Q000097:blood*; D015415:Biomarkers / Q000097:blood*; D006801:Humans
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers
keywords: Alzheimer’s disease; amyloid beta; amyloid cascade hypothesis; amyloid fibrils; biomarkers; dementia; oligomers; plasma; sink model; tau